# Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension

> **NCT02312544** · PHASE2 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** OTX-TP
- **DRUG:** Timolol

## Key facts

- **NCT ID:** NCT02312544
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02312544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02312544, "Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02312544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*